These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 16061830)

  • 1. Transsphenoidal surgery in acromegaly investigated by intraoperative high-field magnetic resonance imaging.
    Fahlbusch R; Keller Bv; Ganslandt O; Kreutzer J; Nimsky C
    Eur J Endocrinol; 2005 Aug; 153(2):239-48. PubMed ID: 16061830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ten-year follow-up results of transsphenoidal microsurgery in acromegaly.
    Biermasz NR; van Dulken H; Roelfsema F
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4596-602. PubMed ID: 11134114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraoperative magnetic resonance imaging-assisted transsphenoidal pituitary surgery in patients with acromegaly.
    Bellut D; Hlavica M; Schmid C; Bernays RL
    Neurosurg Focus; 2010 Oct; 29(4):E9. PubMed ID: 20887134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraoperative high-field magnetic resonance imaging in transsphenoidal surgery of hormonally inactive pituitary macroadenomas.
    Nimsky C; von Keller B; Ganslandt O; Fahlbusch R
    Neurosurgery; 2006 Jul; 59(1):105-14; discussion 105-14. PubMed ID: 16823306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical, hormonal and magnetic resonance imaging (MRI) predictors of transsphenoidal surgery outcome in acromegaly.
    Bourdelot A; Coste J; Hazebroucq V; Gaillard S; Cazabat L; Bertagna X; Bertherat J
    Eur J Endocrinol; 2004 Jun; 150(6):763-71. PubMed ID: 15191345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of acromegaly by endoscopic transsphenoidal surgery: surgical experience in 214 cases and cure rates according to current consensus criteria.
    Hazer DB; Işık S; Berker D; Güler S; Gürlek A; Yücel T; Berker M
    J Neurosurg; 2013 Dec; 119(6):1467-77. PubMed ID: 24074496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reliability of the oral glucose tolerance test in the early postoperative assessment of acromegaly remission.
    Kristof RA; Neuloh G; Redel L; Klingmüller D; Schramm J
    J Neurosurg; 2002 Dec; 97(6):1282-6. PubMed ID: 12507124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term endocrinological follow-up evaluation in 115 patients who underwent transsphenoidal surgery for acromegaly.
    Freda PU; Wardlaw SL; Post KD
    J Neurosurg; 1998 Sep; 89(3):353-8. PubMed ID: 9724106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transsphenoidal surgery for acromegaly in wales: results based on stringent criteria of remission.
    De P; Rees DA; Davies N; John R; Neal J; Mills RG; Vafidis J; Davies JS; Scanlon MF
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3567-72. PubMed ID: 12915637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A retrospective hormonal and immunohistochemical evaluation of 47 acromegalic patients: prognostic value of preoperative plasma prolactin.
    De Marinis L; Zuppi P; Valle D; Mancini A; Bianchi A; Lauriola L; Pasquini P; Anile C; Maira G; Giustina A
    Horm Metab Res; 2002 Mar; 34(3):137-43. PubMed ID: 11972303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The common consensus criteria have high predictive values for long-term postoperative acromegaly remission.
    Kristof RA; Grote A; Redel L; Neuloh G; Klingmüller D; Schramm J
    Acta Neurochir (Wien); 2011 Jan; 153(1):19-25. PubMed ID: 20845050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraoperative high-field MRI for transsphenoidal reoperations of nonfunctioning pituitary adenoma.
    Berkmann S; Schlaffer S; Nimsky C; Fahlbusch R; Buchfelder M
    J Neurosurg; 2014 Nov; 121(5):1166-75. PubMed ID: 25127413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endoscopic endonasal transsphenoidal surgery for growth hormone-secreting pituitary adenomas.
    Hofstetter CP; Mannaa RH; Mubita L; Anand VK; Kennedy JW; Dehdashti AR; Schwartz TH
    Neurosurg Focus; 2010 Oct; 29(4):E6. PubMed ID: 20887131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility of Polestar N20, an ultra-low-field intraoperative magnetic resonance imaging system in resection control of pituitary macroadenomas: lessons learned from the first 40 cases.
    Gerlach R; du Mesnil de Rochemont R; Gasser T; Marquardt G; Reusch J; Imoehl L; Seifert V
    Neurosurgery; 2008 Aug; 63(2):272-84; discussion 284-5. PubMed ID: 18797357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoscopic vs microsurgical transsphenoidal surgery for acromegaly: outcomes in a concurrent series of patients using modern criteria for remission.
    Starke RM; Raper DM; Payne SC; Vance ML; Oldfield EH; Jane JA
    J Clin Endocrinol Metab; 2013 Aug; 98(8):3190-8. PubMed ID: 23737543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of ultra-low-field intraoperative magnetic resonance imaging on extent of resection and frequency of tumor recurrence in 104 surgically treated nonfunctioning pituitary adenomas.
    Hlavica M; Bellut D; Lemm D; Schmid C; Bernays RL
    World Neurosurg; 2013 Jan; 79(1):99-109. PubMed ID: 23043996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Octreotide as primary therapy for acromegaly.
    Newman CB; Melmed S; George A; Torigian D; Duhaney M; Snyder P; Young W; Klibanski A; Molitch ME; Gagel R; Sheeler L; Cook D; Malarkey W; Jackson I; Vance ML; Barkan A; Frohman L; Kleinberg DL
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3034-40. PubMed ID: 9745397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical indicators of biochemical remission in acromegaly: does incomplete disease control always mean therapeutic failure?
    Damjanovic SS; Neskovic AN; Petakov MS; Popovic V; Macut D; Vukojevic P; Joksimovic MM
    Clin Endocrinol (Oxf); 2005 Apr; 62(4):410-7. PubMed ID: 15807870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transsphenoidal pituitary macroadenomas resection guided by PoleStar N20 low-field intraoperative magnetic resonance imaging: comparison with early postoperative high-field magnetic resonance imaging.
    Wu JS; Shou XF; Yao CJ; Wang YF; Zhuang DX; Mao Y; Li SQ; Zhou LF
    Neurosurgery; 2009 Jul; 65(1):63-70; discussion 70-1. PubMed ID: 19574826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does partial surgical tumour removal influence the response to octreotide-LAR in acromegalic patients previously resistant to the somatostatin analogue?
    Jallad RS; Musolino NR; Kodaira S; Cescato VA; Bronstein MD
    Clin Endocrinol (Oxf); 2007 Aug; 67(2):310-5. PubMed ID: 17555503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.